IRAK1 and hepatocellular carcinoma: Li showed that STK4 in macrophage inhibited TLR4/9-induced inflammatory factor secretion, enhanced TLR3/4-triggeredd IFN-β production by binding to and degrading IRAK1, and similar results were obtained in inflammation-induced hepatocellular carcinoma 23.